Sedare Biosciences, Inc. — Form D
Sedare Biosciences, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-23. The offering totals $4.1M, of which $2.5M was reported sold. Industry: Other Technology.
Offering
- Filed: 2024-01-23
- Form: D
- Accession: 0002008582-24-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $4.1M
- Amount sold: $2.5M
- Remaining: $1.6M
- Investors: 1
- Date of first sale: 2024-01-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-503201
Issuer
- Name: Sedare Biosciences, Inc.
- CIK: 0002008582
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 628 MIDDLEFIELD ROAD, PALO ALTO, CA, 94301
- Phone: 612-710-1954
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Donald McCarthy | Director | Palo Alto, CA |
| David Parry | Director | Palo Alto, CA |
| Christian Richard | Director | Palo Alto, CA |
| Donald McCarthy | Executive Officer | Palo Alto, CA |
| David Parry | Executive Officer | Palo Alto, CA |
| Ravichandran Rao | Executive Officer | Palo Alto, CA |
More